SavedAdd your journal

Journals / Ortadoğu Tıp Dergisi / 2014 / Cilt: 6 - Sayı: 2

Evaluatıon of Two Nosocomıal Urinary Tract Infection Casea Due to Trichosporon asahii

Trichosporon asahiiye Bağlı Olarak Nozokomiyal Üriner Sistem Enfeksiyonu Gelişen Olgularımızın Değerlendirilmesi

Nilgün ALTIN
Ayşe TEKİN
Kamer KOLDAŞ
Göknur TOROS YAPAR
İrfan ŞENCAN
Salih CESUR
Pages
102–104
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, two cases of nosocomial urinary tract infection due to Trichosporon asahii at Etlik Training and Re- search Hospital, Intensive Care Unit were presented and discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Trichosporon asahii is an causative agent of superfisial mycosis and opportunistic mycosis and are found widely innature, it rarely cause human infection.
📊
Key Findings & Data:As sporadic cases have been reported in patients with chronic disease and hada indwelling catheter especially immunocompromised patients in intensive care units.
💡
Conclusion & Impact:In this article, two cases of nosocomial urinary tract infection due to Trichosporon asahii at Etlik Training and Re- search Hospital, Intensive Care Unit were presented and discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Trichosporon asahii is an causative agent of superfisial mycosis and opportunistic mycosis and are found widely innature, it rarely cause human infection. As sporadic cases have been reported in patients with chronic disease and hada indwelling catheter especially immunocompromised patients in intensive care units. In this article, two cases of nosocomial urinary tract infection due to Trichosporon asahii at Etlik Training and Re- search Hospital, Intensive Care Unit were presented and discussed.

Özet

Trichosporon asahii doğada yaygın olarak bulunan ve insanlarda nadiren enfeksiyona neden olabilen yüzeyel vefırsatçı mikoz etkeni bir mantardır. Özellikle yoğun bakım ünitelerinde yatan immun sistemi baskılanmış, kronikhastalığı ve kateteri olan hastalarda sporadik olgular şeklinde bildirilmiştir. Bu makalede, Etlik İhtisas Hastanesi Yoğun Bakım Ünitesinde Trichosporon asahii ye bağlı olarak nozokomiyalüriner sistem enfeksiyonu gelişen iki olgu sunularak literatür tartışıldı.

🔖

Cite This Article

ALTIN, N., TEKİN, A., KOLDAŞ, K., YAPAR, G. T., ŞENCAN, İ., CESUR, S. (2022). Evaluatıon of Two Nosocomıal Urinary Tract Infection Casea Due to Trichosporon asahii. Ortadoğu Tıp Dergisi, Cilt: 6 - Sayı: 2, 102–104. https://ajindex.com/articles/585890

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Ebright JR, Fairfax MR, Vazquez JA. Trichosporon asahii, a Non-CandidaYeast That Caused Fatal Septic Shock in a Patient without Cancer or Neutropenia Clinical Infectious Diseases 2001; 33: 28–30
  2. Yıldız O. Önemi artan bir infeksiyon etkeni: Trichosporon. 2007, Cilt 21, Ek, Sayfa: 133-140
  3. Dana G. Wolf, Rama Falk, Moshe Hacham, Bart Theelen, Teun Boekhout, Glorıa Scorzettı, et al. Multidrug-Resistant Trichos- poron asahii Infection of nongranulocytopenic patients in three intensive care units. Journal Of Clinical Microbiology, 2001, 39: 4420–4425
  4. Chowdhary A, Ahmad S, Khan ZU, Doval DC, Randhawa HS. Trichosporon asahii as an emerging etiologic agent of dissemina- ted trichosporonosis: a case report and an Update. Indian Journal of Medical Microbiology,2004; 22 (1):16-22
  5. Takamura S, Oono T, Kanzaki H, Arata J. Disseminated tric- hosporonosis with Trichosporon asahii. Eur J Dermatol 1999; 9:577–9
  6. Kremery V, Mateicka F, Kunova A, et al. Hematogenous tric- hosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazole. Support Care Cancer 1999; 7:39–43. 8.Kontoyiannis DP, Torres HA, Chagua M, et al. Trichosporonosis in a tertiary care cancer center: risk factors,changing spectrum and determinants of outcome. Scand J Infect Dis 2004; 36: 564-569.